CASE STUDY Life science companies face many challenges as they develop, especially over access for researchers to relevant scientific content. In particular, companies that were founded in academic institutions can struggle to provide content access that is organized, comprehensive, and copyright-aware. Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer, with over 250 employees worldwide. Founded in 1999, Genmab has headquarters in Copenhagen, Denmark, and has subsidiaries in the Netherlands and the United States. Through its development the past 20 years, Genmab addresses its critical information needs with tools that allowed researchers to get the information they need

Join for free to read